Home  »  Companies   »  Nevro Corp. (NVRO) – Don’t Believe the...

Nevro Corp. (NVRO) – Don’t Believe the Hype: Check The Facts

Nevro Corp. (NYSE: NVRO) is -45.82% lower on its value in year-to-date trading and has touched a low of $34.70 and a high of $98.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVRO stock was last observed hovering at around $42.59 in the last trading session, with the day’s gains setting it 1.33% off its average median price target of $43.50 for the next 12 months. It is also 41.44% off the consensus price target high of $75.00 offered by 15 analysts, but current levels are -41.68% lower than the price target low of $31.00 for the same period.

Currently trading at $43.92, the stock is 6.07% and 3.03% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing 3.12% at the moment leaves the stock -15.84% off its SMA200. NVRO registered -50.07% loss for a year compared to 6-month loss of 1.69%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a 6.81% gain in the last 1 month and extending the period to 3 months gives it a -5.00%, and is -1.70% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.09% over the week and 6.02% over the month.

Nevro Corp. (NVRO) has around 945 employees, a market worth around $1.54B and $395.30M in sales. Profit margin for the company is -2.00%. Distance from 52-week low is 26.57% and -55.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-24.50%).

Nevro Corp. (NVRO) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Nevro Corp. (NVRO) is a “Hold”. 15 analysts offering their recommendations for the stock have an average rating of 3.10, where 9 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 2 analysts have rated the stock as a Sell or Underperform.

The EPS is expected to shrink by -52.90% this year

Nevro Corp. (NVRO) Top Institutional Holders

The shares outstanding are 35.40M, and float is at 34.58M with Short Float at 9.64%.

Nevro Corp. (NVRO) Insider Activity

A total of 23 insider transactions have happened at Nevro Corp. (NVRO) in the last six months, with sales accounting for 5 and purchases happening 18 times. The most recent transaction is an insider purchase by Rashid Kashif, the company’s General Counsel. SEC filings show that Rashid Kashif bought 2,250 shares of the company’s common stock on May 09 at a price of $44.50 per share for a total of $0.1 million. Following the purchase, the insider now owns 53526.0 shares.

Nevro Corp. disclosed in a document filed with the SEC on Mar 11 that Rashid Kashif (General Counsel) bought a total of 1,500 shares of the company’s common stock. The trade occurred on Mar 11 and was made at $64.04 per share for $96067.0. Following the transaction, the insider now directly holds 51276.0 shares of the NVRO stock.

Still, SEC filings show that on Mar 08, GROSSMAN D KEITH (Chairman, President & CEO) acquired 3,200 shares at an average price of $63.59 for $0.2 million. The insider now directly holds 169,290 shares of Nevro Corp. (NVRO).

Nevro Corp. (NVRO): Who are the competitors?

The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading -13.51% down over the past 12 months and Abiomed Inc. (ABMD) that is 15.11% higher over the same period. Intuitive Surgical Inc. (ISRG) is -21.27% down on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.